I can hear the arguments now. The side effects are the same symptoms as the target population as a whole. blah blah blah. The truth is who could tell with 8 patients in US? Totally IMO but my guess is they'll say enroll more subjects and come back then. Still alive anyway.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.